As previously reported, avasopasem reduced cisplatin-related chronic kidney disease by 50% compared to placebo at one-year follow-up
Additional data demonstrated improved preservation of kidney function at month 3 through one year in avasopasem-treated patientsBased on ROMAN oral mucositis data,…
Source: www.marketscreener.com – Read more
Fast-moving Storm-1175 uses new exploits to breach networks and drop Medusa – Security Affairs
Fast-moving Storm-1175 uses new exploits to breach networks and drop Medusa Security Affairs
